8-K: CIMG Inc. Regains Nasdaq Compliance with $49.52M Equity

CIMG Inc. announced it has achieved compliance with Nasdaq's shareholders' equity requirement, reporting approximately $49.52 million in equity following recent capital raises.

Summary

• CIMG Inc. affirmed its compliance with Nasdaq Listing Rule 5550(b)(1) (the Equity Requirement) as of November 12, 2025, reporting approximately $49.52 million in shareholders' equity.
• This compliance follows a Nasdaq Hearings Panel decision on September 2, 2025, which granted continued listing subject to the company meeting specified conditions, including the Equity Requirement by September 30, 2025.
• To achieve compliance, the company completed several equity issuances between June 30, 2025, and September 30, 2025.
• On August 21, 2025, the company entered into a Convertible Note Purchase Agreement for $4,000,000, with notes convertible at $0.24 per share. An initial 8,333,333 shares were issued on September 9, 2025, with remaining conversions in October 2025.
• On September 2, 2025, a private offering closed, raising $55,000,000 for 220,000,000 shares at $0.25 per share. 148,100,000 shares were issued upon closing, with the remaining 71,900,000 shares issued in October 2025.
• Subsequent to September 30, 2025, additional equity issuances occurred, including the remaining private offering shares (71,900,000 on October 29, 2025), remaining note conversions (8,333,333 on October 30, 2025), and full exercise of outstanding warrants (25,641,023 on October 30, 2025), generating approximately $10,000,000 in gross proceeds. These subsequent events further strengthen the capital position but are not reflected in the September 30, 2025 balance sheet.

Sentiment

Score: 8

Explanation: The company successfully resolved a critical listing compliance issue by significantly strengthening its capital position through multiple equity raises, which is a strong positive for its continued operation as a public entity.

Positives

• Achieved compliance with Nasdaq's Equity Requirement, ensuring continued listing on The Nasdaq Stock Market.
• Shareholders' equity significantly increased to approximately $49.52 million, well above the $2.5 million minimum required by Nasdaq.
• Successfully raised substantial capital through convertible notes ($4,000,000), a private offering ($55,000,000), and warrant exercises (approximately $10,000,000).
• Strengthened capital position, which supports long-term compliance and operational stability.

Negatives

• The company was previously non-compliant with Nasdaq's listing requirements, necessitating these capital raises.
• Significant dilution occurred due to the issuance of a large number of new shares (8,333,333 from notes, 220,000,000 from private offering, 25,641,023 from warrants).

Risks

• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expected results.
• General risks and uncertainties are detailed in the company's Annual Report on Form 10-K for the year ended September 30, 2024, and subsequent SEC filings.
• The pro forma balance sheet has not been audited or reviewed by an independent registered public accounting firm, and adjustments may be required.

Future Outlook

The company expects to comply with the Nasdaq Equity Requirement on a long-term basis. Subsequent equity transactions completed after September 30, 2025, are believed to further strengthen its capital position and support continued listing on The Nasdaq Capital Market.

Management Comments

• "The Company believes that it has achieved compliance with, and it furthermore expects to comply on a long-term basis with, the Equity Requirement under Nasdaq Listing 5550(b)(1)."
• "The Company awaits Nasdaqs confirmation that the Company has successfully evidenced that compliance."
• "The Company believes that the equity transactions completed through September 30, 2025 demonstrate compliance with the Equity Requirement and that subsequent events further strengthen its capital position and support continued listing on The Nasdaq Capital Market."

Industry Context

This announcement reflects a common challenge for smaller public companies to maintain listing compliance, especially during periods of financial strain or growth. Successful capital raises to meet exchange requirements are crucial for maintaining market access and investor confidence. The significant capital infusion suggests a strong effort to stabilize the company's financial foundation and retain its public listing, which is vital for liquidity and future fundraising.

Legal Proceedings

• Following a hearing held on August 14, 2025, the Nasdaq Hearings Panel issued a decision on September 2, 2025, granting the Company's request to continue listing on The Nasdaq Stock Market, subject to the Company's timely satisfaction of specified conditions, including filing all required periodic reports and demonstrating compliance with the Nasdaq Listing Rule 5550(b)(1).

Related Party Transactions

• The unaudited pro forma balance sheet as of September 30, 2024, lists a 'Convertible Note-related party' of $319,220.
• The unaudited pro forma balance sheet as of September 30, 2024, lists 'Other payables-related party' of $7,500.

Stakeholder Impact

• Shareholders: Positive impact as the risk of delisting from Nasdaq has been mitigated, preserving liquidity and investment value. However, significant dilution occurred due to new share issuances.
• Investors (new): Provided an opportunity to invest in the company through convertible notes, private placement, and warrant exercises.
• Nasdaq: The company has met the conditions set by the Nasdaq Hearings Panel, upholding the integrity of the exchange's listing standards.

Next Steps

• The company awaits Nasdaq's confirmation of its compliance with the Equity Requirement.

Key Dates

Recommendation

The filing indicates a significant positive development by resolving the Nasdaq listing compliance issue and substantially strengthening the company's balance sheet through capital raises. This removes a major overhang and risk factor. However, the filing does not provide details on the company's operational performance, strategic direction, or long-term profitability, which are crucial for a 'buy' recommendation. The substantial dilution from the capital raises also needs to be considered. Therefore, a 'hold' recommendation is appropriate, acknowledging the improved financial stability while awaiting further operational insights.

Keywords

Nasdaq compliance, equity raise, private placement, convertible notes, warrant exercise, shareholders' equity, capital market, listing requirements, CIMG Inc.